Oncology Pharma Inc. ONPH
0.04 USD 0.00 (+0.00%)
Nov 4, 2026, 12:20 PM EST
0.04 Day range 0.04
0.0001 52-week range 0.364
- YTD
- +900.00%
- 1 year
- +19,900.00%
- Market cap
- 3.29M
- EPS (ttm)
- -0.23
- YTD return
- +900.00%
- 1-year return
- +19900.00%
- Volume
- 625
- Avg volume
- 16.32K
- Open
- 0.04
- Previous close
- 0.04
- Day's range
- 0.04 – 0.04
- 52-week range
- 0.0001 – 0.364
2Y +0.0399 (+39900.00%)
News
Head to Head Comparison: Oncology Pharma (OTCMKTS:ONPH) & Rafael (NYSE:RFL) 
Head-To-Head Survey: Oncology Pharma (OTCMKTS:ONPH) vs. Larimar Therapeutics (NASDAQ:LRMR) 
Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing 
Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product 
Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives 
Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc. 
Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP 
Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase 
Shares of This Biotech Stock Could Jump 437% 
Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer
Your note
Sign in to keep a note on ONPH — it syncs with the Stock Master app.